
A total of 18 patients received zzso ambulatory infusions of zzso in groups at dose levels of 14, 28, 35 and 42 zzso per zzso The zzso toxicity was zzso At 42 zzso three of four patients had WHO grade 4 and one of four had grade 3 zzso whereas two patients had grade 3 zzso At 35 zzso two of five patients had grade 3 zzso whereas one had grade 4 and two had grade 3 zzso zzso zzso were predominantly zzso with 3 of 18 patients experiencing grade 3 zzso Total and zzso platinum zzso were zzso by zzso atomic zzso zzso in weekly and zzso plasma and urine zzso In zzso levels of total platinum increased throughout the infusion, and the protein binding slowly increased from zzso platinum bound at week 1 to zzso bound by week zzso Although the zzso level reached a steady state within 1 week, the concentration did not increase with the dose level, remaining at a mean value of zzso zzso zzso zzso Renal zzso of platinum accounted for 70 zzso zzso of the dose at steady zzso There was a high zzso zzso in both total body clearance of zzso zzso zzso zzso and zzso clearance zzso zzso zzso A terminal elimination zzso of zzso h was noted for zzso zzso zzso was zzso related to the total daily zzso dose, but neither zzso nor zzso could be related to zzso zzso or the zzso area under the zzso curve zzso The recommended dose for phase II studies is 28 zzso per zzso 

